Rapid rise in share price (the stock reached a SP level too high for it's risk profile based on the below IMO). SPECULATIVE
PromarkerD flopping in all jurisdictions it has launched in - no reason provided by Richard - just radio silence. VALID POINT BUT COVID IS WORLD FOCUS
No licencing deal with Jansen following the supposedly good result (I was lead to beleive that folloiwng this validation, PIQ would start selling in US). JANSEN HAS NOT FINISHED YET FOR DEAL
New "validations" keep coming out randomly. How many times does it need to be validated? NONSENSE
Lack of business plan - it seems they are just aimlessly ticking some boxes here and there, but how these boxes link, or how many more boxes need to be ticked? Anyones guess since PIQ don't tell you - do they not know themselves? SOUNDS LIKE MORE NONSENSE
No indication on timelines for cash flow from PromarkerD. TRUE BUT WE WAIT FOR JANSEN
PIQ Price at posting:
91.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
SOUNDS LIKE MORE NONSENSE
(20min delay)